Larson Financial Group »

Seres Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $39 5 7.80

More positions owned by Larson Financial Group

Spdr Series Trust St Str P500etf (SPYM)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Apple (AAPL)
Applied Materials (AMAT)
Capital Group Global Equity SHS (CGGE)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Intl Qualty (IQLT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Capital Grp Fixed Incm Etf T Core Bond Etf (CGCB)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Lam Research Corp Com New (LRCX)

View all positions for Larson Financial Group

Top funds holding Seres Therapeutics

Flagship Ventures Management
Vanguard Capital Management
Marshall Wace
Susquehanna International
Vontobel Holding
BlackRock
Geode Capital Management
Citadel Advisors
Vanguard Fiduciary Trust
State Street Corporation
Lion Point Capital
Charles Schwab Investment Management
Sixth Street Partners Management Company
American Century Companies
Morgan Stanley

View all funds holding Seres Therapeutics